Alergia: badanie kliniczne

Gdzie prowadzone jest badanie

Ośrodki prowadzące badanie w Polsce (1), alfabetycznie według miejscowości:

• Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Wkrótce rekrutacja
  WarszawaKontakt

Więcej badań w tych miastach:

• Warszawa

Stan rekrutacji pochodzi z rejestrów badań i może się zmienić szybciej, niż zaktualizuje go sponsor. Nasz doradca sprawdzi aktualny stan w wybranym ośrodku. Nie publikujemy nazwisk lekarzy ani ich danych kontaktowych.

Cel badania

Opis z rejestru (w języku angielskim):

Cow's milk allergy (CMA) is a common food allergy in infants and young children that can have a significant impact on the individual and their family due to dietary restrictions, risk of nutritional deficiencies, social limitations, and decreased quality of life. It also represents a financial burden for families and healthcare resources.

There is an ongoing debate about the significance of early exposure to cow's milk proteins within hours or days after birth and its relationship to the risk of developing CMA later in life. Current recommendations for early introduction of cow's milk proteins in infants who cannot be breastfed vary and are inconsistent due to a lack of clear evidence. This knowledge gap underscores the need for further research to provide a definitive understanding of the relationship between early exposure to cow's milk proteins and the development of CMA, which will ultimately inform evidence-based prevention strategies to improve the health and well-being of affected individuals and their families.

This trial aims to investigate whether early supplementation with various nutritional interventions (cow's milk formula \[CMF\], amino acids formula \[AAF\], donor human milk \[DHM\], or high-pressure processed "pascalized" donor human milk \[DHM-P\]) could serve as an effective strategy for the primary prevention of CMA in breastfed neonates.

This study is an open-label randomized, controlled, head-to-head trial with four parallel arms and allocation 1:1:1:1.

Leczenie w badaniu

Kryteria udziału

Kryteria w języku angielskim, tak jak w rejestrze.

To główne kryteria z rejestru. Pełną listę i ostateczną decyzję o udziale ustala lekarz prowadzący badanie.

Inne badania: alergia

Rekrutuje

Badanie kliniczne

Effectiveness and Safety of Milk Ladders in Children with IgE-Mediated Cow's Milk Protein Allergy

Miasta: WarszawaWiek: 1-5 latSponsor: Medical University of Warsaw

Rekrutuje

Badanie kliniczne

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

Miasta: Białystok, Bydgoszcz, Janki, Kraków i 5 innych miastWiek: do 0.67 latSponsor: Société des Produits Nestlé (SPN)

RekrutujeFaza III

Badanie fazy III leku desloratadine i prednisolone

A long-term, double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of PQ Grass 27600 SU in children and adolescents with seasonal…

Badane leki: desloratadineprednisoloneloratadineolopatadine hydrochloride

Miasta: Białystok, Częstochowa, Gdańsk, Kraków i 6 innych miastWiek: do 17.99 latSponsor: Allergy Therapeutics (UK) Limited

Rekrutuje

Badanie kliniczne

Efficacy of Cashew Nut Protein Immunotherapy

Miasta: WarszawaWiek: 4-17 latSponsor: Medical University of Warsaw

Rekrutuje

Badanie kliniczne

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Miasta: WarszawaWiek: 3-17 latSponsor: Medical University of Warsaw

Rekrutuje

Badanie kliniczne

Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy

Miasta: WarszawaWiek: 4-17 latSponsor: Medical University of Warsaw

Wszystkie badania: alergia